Related Experiment Video
Updated: May 19, 2026
05:39
Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
Published on: October 30, 2018
[Increasing immunization coverage in adults and elderly by creating structural relationships with general
M Conversano1, M Busatta, R Cipriani
1Dipartimento di Prevenzione ASL Taranto. dip.conversano@libero.it
Annali Di Igiene : Medicina Preventiva E Di Comunita
|August 14, 2012
Summary
Creating strong collaborations between preventive medicine specialists and general practitioners is key to increasing adult vaccination coverage. This network approach mirrors successful childhood immunization strategies.
Area of Science:
- Public Health
- Preventive Medicine
- Healthcare Collaboration
Context:
- Achieving high vaccination coverage in adults, the elderly, and high-risk populations remains a challenge.
- Pediatric vaccination programs demonstrate the effectiveness of collaborative networks.
Purpose:
- To propose a strategy for enhancing adult vaccination coverage through improved healthcare professional collaboration.
- To leverage existing successful models for broader public health impact.
Summary:
- Establishing a robust network between preventive medicine specialists and general practitioners is essential.
- This collaboration should extend to community health districts and departments of prevention.
- Developing joint training programs will foster necessary synergies.
Impact:
- Increased vaccination rates in adult, elderly, and high-risk groups.
- Strengthened public health infrastructure through interprofessional partnerships.
- Improved health outcomes and disease prevention across the lifespan.
Related Concept Videos
01:51Vaccinations
Overview
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:30Preventive Healthcare Services
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...